SAra Sidine, anchor and senior national correspondents of the CNN, told the presence of a healthy impact in Time100 on Tuesday night that 16 rounds of chemotherapy after diagnosing breast cancer were diagnosed in the third stage in 2023 – and worked all the time. The room broke out loudly.
“It is possible to live your life while trying to kill cancer,” said Sidine. “We have come a long way, and I want to say to this room: Any person in this room is a nurse, a doctor, a doctor, a researcher, a person who makes drugs to us – thank you. Thank you for the search. Thank you for your work; we need this a lot.”
He joined Sidner on stage by Dr. Vinod Balshandran, the surgeon’s scientist and director of the Olayan Cancer Center at the Memorial Celong Cancer Center, and Victor Bolo, head of the American unit in Novartis, who sponsored the event in New York City. The three appeared on a painting moderated by the Time Health Alice Park to discuss the leading innovations in detecting cancer, treatment and prevention – and the research that still should be done.
Sidner, which is a 2025 Closers at the time of the honoreesShe said she has not always planned to share her cancer diagnosis publicly. But when she learned that she had breast cancer in the third stage, she realized that she would not be able to keep him secret from everyone.
“Your life has spent telling the stories of others – perhaps this is something you need to narrate, and tell it in a truly honest, sometimes embarrassing way, tell people what is like this trip,” you remember thinking.
Balshandran, which is a 2025 Time100 Health HonoreeAnd cancer called “the most urgent health crisis in our lives.” In the United States, one in three women will be diagnosed with cancer during their lives, according to American Cancer Association.
He said that part of what is a challenge is that cancer is “a smart cell that is constantly programmed to develop.”
“We have historically dealt with drugs that do not develop with advanced cancer,” said Palshandran. “Although cancer is smart, we do not fight it with a smart drug. We have always imagined the development of smart drugs to diagnose and treat cancer, but we were not really able to achieve this goal.”
Now, though, Balachandran said he believed the health industry has made progress in this. Balshandran said that new technologies, including artificial intelligence and research developments – such as understanding how to identify the cancer immune system – can help medical service providers to diagnose cancer early and treat cancer more effectively. It has been used in shoresran Marna Technology To create dedicated vaccines, the research indicated that the patient’s immune system was strengthened to help treat pancreatic cancer. Pancreatic cancer is The third cause of the death of cancer In the United States
Bolo said it is necessary to continue to put reasons on the medicine, but also to understand the patient’s experience.
“On the one hand, we have a lot to do on the Science Front, but also, the more we learn from science, the more we learn … we must become good or innovative in how to bring these medications to patients over the innovation of the drugs themselves.” “We spent a lot of time trying to understand the live experience of patients, and the experience of feeling sick.”
He said that whatever innovations developed to treat cancer, it is important to ensure that they are distributed to all the patients they need – whether they live in New York City or in a rural society.
At the same time that developments are presented in the field of cancer, Research financing through the National Institutes of Health in the United States is at risk Under Trump’s management. Nevertheless, Palshandran said he was “optimistic.”
He said: “We have made a lot of progress, so it is really difficult to stop this level of progress when the results are truly transformational and a kind of cancellation in the next era from cancer care.” “If they do, how can you not support it? Because cancer is something that affects all of us.”
To close the discussion, Park asked the committee members: Will we heal the cancer?
He replied with the immediately: Yes.
“We are already treating cancer,” he said. “The question is: How can we treat cancer, and how can we treat cancer more effectively, and how can we treat cancer more simply with lower side effects or less medicines, and for whom and people?”
“The next revolution of cancer care revolves around expanding access to more patients, and expanding more treatments with less side effects for people.”
Sidner and Bulto said they agreed with Balacchandran, but Sidner added that it was very important to ensure cancer treatment repeatedly. She indicated that black women Almost 40 % are more likely From their white counterparts to die from breast cancer.
“There is something wrong there,” she said. “So who will be treated with cancer is a huge question that must be treated.”
The Time100 Impact Dinner: Leaders who make up the future of health sponsored Novartis and Figs.
